Literature DB >> 16516601

Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging.

Stéphane Nottin1, Long-Dang Nguyen, Mohamed Terbah, Philippe Obert.   

Abstract

The effects of anabolic androgenic steroids (AASs) on left ventricular (LV) diastolic function in strength-trained athletes are controversial. The main objective of this study was to evaluate the effects of regular AAS administration in bodybuilders using pulsed tissue Doppler imaging (TDI) to evaluate LV relaxation properties. Fifteen male bodybuilders with a history of intensive, long-term strength training and 16 age-matched sedentary controls were recruited. Six of the bodybuilders reported regular use of AASs, and 9 were drug free. To assess LV diastolic function, each subject underwent standard Doppler echocardiography and pulsed TDI. Drug-using bodybuilders exhibited altered LV diastolic filling characterized by a smaller contribution of passive filling to LV filling compared with their drug-free counterparts. TDI measurements indicated that drug-using bodybuilders had smaller peak E(m) than drug-free bodybuilders and sedentary controls, except at the level of the anterior wall, at which peak E(m) was significantly smaller than in drug-free bodybuilders only. The E/E(m) ratio, an index of LV filling pressures, was not affected by strength training or by AAS use. Drug-using bodybuilders exhibited larger LV end-diastolic diameters, volumes, and masses than their drug-free counterparts. However, no difference was found in LV wall thickness between the groups. In conclusion, drug-using bodybuilders showed a decrease in the contribution in LV passive filling to LV filling associated with a decrease in LV relaxation properties. Because no wall thickening was obtained in drug-using bodybuilders, the decrease in LV relaxation properties might have been be due to an alteration in the active properties of the myocardium, but that has yet to be confirmed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516601     DOI: 10.1016/j.amjcard.2005.10.026

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  Short QT interval: A novel predictor of androgen abuse in strength trained athletes.

Authors:  Mohammad Ali Babaee Bigi; Amir Aslani; Arsalan Aslani
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

Review 2.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

3.  Left atrial myocardial dysfunction after chronic abuse of anabolic androgenic steroids: a speckle tracking echocardiography analysis.

Authors:  Antonello D'Andrea; Juri Radmilovic; Stefano Caselli; Andreina Carbone; Raffaella Scarafile; Simona Sperlongano; Giampaolo Tocci; Tiziana Formisano; Francesca Martone; Biagio Liccardo; Michele D'Alto; Eduardo Bossone; Maurizio Galderisi; Paolo Golino
Journal:  Int J Cardiovasc Imaging       Date:  2018-10       Impact factor: 2.357

4.  The Effect of Chronic Anabolic-Androgenic Steroid Use on Tp-E Interval, Tp-E/Qt Ratio, and Tp-E/Qtc Ratio in Male Bodybuilders.

Authors:  Elnur Alizade; Anıl Avcı; Serdar Fidan; Mustafa Tabakçı; Mustafa Bulut; Regayip Zehir; Zeki Simsek; Mert Evlice; Uğur Arslantaş; Hakan Çakır; Mehmet Yunus Emiroglu; Mustafa Akçakoyun
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-01-28       Impact factor: 1.468

5.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

Review 6.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

7.  Cardiac tissue Doppler imaging in sports medicine.

Authors:  Anne Krieg; Jürgen Scharhag; Wilfried Kindermann; Axel Urhausen
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

8.  Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.

Authors:  Aaron L Baggish; Rory B Weiner; Gen Kanayama; James I Hudson; Michael T Lu; Udo Hoffmann; Harrison G Pope
Journal:  Circulation       Date:  2017-05-23       Impact factor: 29.690

Review 9.  Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.

Authors:  Suraj Achar; Armand Rostamian; Sanjiv M Narayan
Journal:  Am J Cardiol       Date:  2010-09-15       Impact factor: 2.778

Review 10.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.